Trial Profile
MOTIV Study. Effect of Antidepressive Treatment by Escitalopram Started Preoperatively in Patients Undergoing Coronary Artery Bypass Grafting
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Escitalopram (Primary)
- Indications Depressive disorders
- Focus Therapeutic Use
- Acronyms MOTIV; MOTIV-CABG
- 16 Mar 2012 Actual patient number (368) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 16 Mar 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.